focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,166.00
Bid: 12,132.00
Ask: 12,136.00
Change: -6.00 (-0.05%)
Spread: 4.00 (0.033%)
Open: 12,180.00
High: 12,198.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks down as BoE confirms end to bond-buying

Wed, 12th Oct 2022 17:00

(Alliance News) - Stock prices in London closed in the red on Wednesday, as discouraging economic data and mixed signals from the UK's central bank weighed on investor sentiment.

The FTSE 100 index closed down 59.08 points, 0.9%, at 6,826.15. The FTSE 250 ended down 292.90 points, 1.7%, at 16,611.16, and the AIM All-Share closed down 11.43 points, 1.5%, at 776.27.

The Cboe UK 100 ended down 0.9% at 681.94, the Cboe UK 250 closed down 2.0% at 14,231.10, and the Cboe Small Companies ended down 1.7% at 12,308.79.

In European equities on Wednesday, the CAC 40 in Paris ended down 0.3%, while the DAX 40 in Frankfurt ended down 0.4%.

The UK economy faced yet more turmoil, with economic data painting a fairly gloomy picture.

The nation's trade deficit widened, its industrial production shrunk and its gross domestic product also weakened.

Figures showed the UK economy shrank by 0.3% in August from July, following a downwardly revised 0.1% climb in July from June. Month-on-month growth in July was initially forecast at 0.2%.

August's gross domestic product was expected to have remained unchanged from July.

"While July's economic health was bolstered by a number of sporting events that got people out and about, August was coloured with caution. Households were terrified about what the winter ahead had in store, as they read headlines predicting horrific energy bills, and witnessed first-hand as inflation squeezed their spending power," said AJ Bell's Danni Hewson.

"Rising prices, falling confidence and cooling temperatures seem to be the perfect recipe for recession and there's every indication that in September the economy will have followed August's path, helped along by a bank holiday detour."

The pound was quoted at USD1.1066 at the London equities close Wednesday, down compared to USD1.1097 at the close on Tuesday. It had hit a two-week low of USD1.0924 earlier in the day.

Sterling saw a turbulent day of trading, following some mixed messages from the Bank of England.

BoE Governor Andrew Bailey confirmed late Tuesday that the emergency interventions would halt this week, but on Wednesday morning, the Financial Times reported the bank had privately signalled it was considering extending the bond-buying programme beyond the Friday deadline.

Later in the day, the bank confirmed the scheme would end on Friday.

"The Bank of England's messaging to the market over the last 24-hours has been conflicted and confused, causing unnecessary gyrations to the pound and adding to the sense of instability in the markets," interactive investor's Victoria Scholar commented.

The euro stood at USD0.9702 at the European equities close Wednesday, down against USD0.9719 at the same time on Tuesday.

Against the yen, the dollar was trading at JPY146.90, sharply higher compared to JPY145.70 late Tuesday.

Meanwhile, producer inflation heated up in the US. Producer prices increased in September, data from the Bureau of Labor Statistics showed, reversing from August's decline and exceeding market expectations.

The producer price index increased 0.4% in September from the previous month, partially reversing declines of 0.2% in August and 0.4% in July.

Market consensus, according to FX Street, had predicted a 0.2% rise.

Investors will have a keen eye on Thursday's US consumer price inflation figures, which will be a key factor in determining the US Federal Reserve's interest rate decision next month.

Stocks in New York were higher at the London equities close, with the DJIA up 0.5%, the S&P 500 index 0.2%, and the Nasdaq Composite up 0.2%.

In the FTSE 100, AstraZeneca edged up 1.1% on "exceptional data" for its drug Ultomiris. Towards the end of this month, AZ's subsidiary Alexion Pharmaceuticals will present data showing "significant advances" for the treatment of a form of neuromyelitis.

At the other end of the index was JD Sports, which lost 9.7%. After some high-profile changes to its once controversial leadership in recent months, the athleisure retailer announced its Chief Financial Officer Neil Greenlagh will step down next year.

JD will now begin the process of recruiting his successor.

Another poor blue chip performer was Barratt Homes, falling 5.0%. The housebuilder warned private reservations are down from a year earlier, as the sector battles a tough economic climate.

"Barratt cites increased wider economic uncertainty thanks to the knock to consumers' confidence and pockets from the increased cost of living, higher interest rates and also a reduction in mortgage availability. All three factors bear the fingerprints of both the government and the Bank of England and the drop in mortgage availability is a direct result of the financial market fall-out which followed the chancellor's botched fiscal event of 23 September," said AJ Bell investment director, Russ Mould.

In a negative read-across fellow housebuilders Persimmon and Crest Nicholson lost 5.8% and 6.6% respectively

In the midcaps, Marks & Spencer lost 4.8%. In a presentation to investors, the grocer said it is accelerating a major shake-up of its stores estate, and will close 67 more shops.

M&S stressed that the previously announced closures will be more than offset by new openings as the group seeks to focus more on its grocery business and online operations.

On AIM, environmental and life science group Deepverge plunged 45%.

The Dublin-based artificial intelligence tech firm warned it may not be able to raise "sufficient equity funds" as repayments for a loan fall due.

It secured a GBP25 million loan in March, of which an initial GBP4 million was drawn. The firm stated that monthly repayments begin on Sunday, with an initial GBP500,000 due.

DeepVerge added there will be no default on the loan despite any missed payments up to November 14, assuming principal and interest payments are made following a proposed equity raise.

Brent oil was quoted at USD92.55 a barrel at the London equities close Wednesday down from USD94.62 late Tuesday. Gold was quoted at USD1,670.16 an ounce, down slightly against USD1,671.20 at the close on Tuesday.

In Thursday's UK corporate calendar, there are trading statements from budget airline easyJet, gambling firm Entain, and recruitment firm Hays.

As well as US CPI and intial jobless claims at 1330 BST, the economic calendar for Thursday has German CPI at 0700 BST, and Ireland CPI at 1100 BST. There will also be remarks from BoE Monetary Policy Committee Member Catherine Mann.

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.